MY101193A - Agent for coccidiosis - Google Patents

Agent for coccidiosis

Info

Publication number
MY101193A
MY101193A MYPI87002276A MYPI19872276A MY101193A MY 101193 A MY101193 A MY 101193A MY PI87002276 A MYPI87002276 A MY PI87002276A MY PI19872276 A MYPI19872276 A MY PI19872276A MY 101193 A MY101193 A MY 101193A
Authority
MY
Malaysia
Prior art keywords
coccidiosis
agent
methyl
trifluoromethylthiophenoxy
trione
Prior art date
Application number
MYPI87002276A
Other languages
English (en)
Inventor
Voege Herbert
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MY101193A publication Critical patent/MY101193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Detergent Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MYPI87002276A 1983-01-12 1987-09-29 Agent for coccidiosis MY101193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833300793 DE3300793A1 (de) 1983-01-12 1983-01-12 Coccidiosemittel
EP83113224A EP0116175B1 (de) 1983-01-12 1983-12-30 Coccidiosemittel

Publications (1)

Publication Number Publication Date
MY101193A true MY101193A (en) 1991-07-31

Family

ID=6188113

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002276A MY101193A (en) 1983-01-12 1987-09-29 Agent for coccidiosis

Country Status (18)

Country Link
EP (1) EP0116175B1 (cg-RX-API-DMAC7.html)
JP (1) JPS59139316A (cg-RX-API-DMAC7.html)
KR (1) KR900007310B1 (cg-RX-API-DMAC7.html)
AT (1) ATE40792T1 (cg-RX-API-DMAC7.html)
AU (1) AU561923B2 (cg-RX-API-DMAC7.html)
CS (1) CS235997B2 (cg-RX-API-DMAC7.html)
DE (2) DE3300793A1 (cg-RX-API-DMAC7.html)
DK (1) DK165668C (cg-RX-API-DMAC7.html)
ES (1) ES528805A0 (cg-RX-API-DMAC7.html)
FI (1) FI81961C (cg-RX-API-DMAC7.html)
HU (1) HU192529B (cg-RX-API-DMAC7.html)
IE (1) IE56522B1 (cg-RX-API-DMAC7.html)
IL (1) IL70641A (cg-RX-API-DMAC7.html)
MY (1) MY101193A (cg-RX-API-DMAC7.html)
PH (1) PH20973A (cg-RX-API-DMAC7.html)
PT (1) PT77916B (cg-RX-API-DMAC7.html)
SU (1) SU1276249A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA84219B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3408768A1 (de) * 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
DE3703105A1 (de) * 1987-02-03 1988-08-11 Bayer Ag Mittel gegen protozoen bei insekten
DE3703103A1 (de) * 1987-02-03 1988-08-11 Bayer Ag Mittel gegen fischparsiten
DE3814323A1 (de) * 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
CZ146296A3 (en) * 1995-06-02 1997-04-16 American Cyanamid Co 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents
RU2202346C2 (ru) * 1997-07-29 2003-04-20 Фармация Энд Апджон Компани Фармацевтическая композиция для кислотных липофильных соединений в форме самоэмульгирующейся композиции
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1476867A (fr) * 1966-03-04 1967-04-14 Wellcome Found Préparation de solutions aqueuses stables contenant un mélange de sulfaquinoxaline et de diavéridine
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
EP0081142B1 (de) * 1981-12-03 1986-06-25 BASF Aktiengesellschaft 1,3,5-Triazinone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses

Also Published As

Publication number Publication date
HU192529B (en) 1987-06-29
JPH0216730B2 (cg-RX-API-DMAC7.html) 1990-04-18
ATE40792T1 (de) 1989-03-15
JPS59139316A (ja) 1984-08-10
SU1276249A3 (ru) 1986-12-07
PT77916B (en) 1986-04-16
IL70641A (en) 1987-01-30
EP0116175A3 (en) 1986-02-19
DK12184D0 (da) 1984-01-11
FI840082A0 (fi) 1984-01-10
PT77916A (en) 1984-02-01
DE3379195D1 (en) 1989-03-23
KR840007355A (ko) 1984-12-07
IL70641A0 (en) 1984-04-30
AU2317284A (en) 1984-07-19
FI81961B (fi) 1990-09-28
DK165668C (da) 1993-06-01
FI81961C (fi) 1991-01-10
PH20973A (en) 1987-06-15
CS235997B2 (en) 1985-05-15
FI840082L (fi) 1984-07-13
ES8500058A1 (es) 1984-10-01
DK12184A (da) 1984-07-13
ZA84219B (en) 1984-09-26
ES528805A0 (es) 1984-10-01
EP0116175A2 (de) 1984-08-22
AU561923B2 (en) 1987-05-21
DE3300793A1 (de) 1984-07-12
IE56522B1 (en) 1991-08-28
EP0116175B1 (de) 1989-02-15
DK165668B (da) 1993-01-04
KR900007310B1 (ko) 1990-10-08
IE840047L (en) 1984-07-12

Similar Documents

Publication Publication Date Title
JO1224B1 (en) Derivatives of SIS, endo-azabicilco- (3,3, zero) -octane-3-carboxylic acid for their preparation, agents containing these compounds and methods of use.
MY101193A (en) Agent for coccidiosis
ES8702371A1 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
ES8507540A1 (es) Un procedimiento para preparar indeno-piridazinonas sustituidas.
GR852979B (cg-RX-API-DMAC7.html)
ES8500225A1 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
CA1230115A (en) ANTHRA[1,9-CD]PYRAZOL-6(2H)-ONES SUBSTITUTES
ES8506306A1 (es) Procedimiento para preparar 6-(tien-2-il)-3(2h)-piridazinonas sustituidas
ES8205810A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ZA839347B (en) New 2-azabicyclo(2.2.1)heptane derivatives,processes for their preparation,agents containing these compounds and their use,and 2-azabicyclo(2.2.1)heptane derivatives as intermediates and processes for their preparation
ZA823602B (en) N-substituted 2-methylnaphthylamides, their preparation, and their use for controlling fungi
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
EP0350080A3 (en) Use of nadolol for inhibiting the onset of migraine headaches
JPS5334773A (en) Benzothiazole derivatives and preventives remedies containing the same for coccidiosis
SU1233456A1 (ru) Способ получения замещенных n-[(1,3,5-триазин-2-ил)аминокарбонил]бензолсульфонамидов
SU1135053A1 (ru) Способ приготовления модифицированной гранулированной окиси алюминия
SU898741A1 (ru) Бромистоводородная соль s-(1-оксо-2-фенил-3-инденил)- n,n′- бис-(3-триэтилсилилпропил)изотиурония в качестве ингибитора агрегации тромбоцитов
JPS57172999A (en) Surfactant composition, manufacture and stabilization of coal-mixed oil
JO1101B1 (en) Method for halogenation, reduction and preparation of emino halides cephalosporins or beta-lactam compounds
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
UA11771A1 (uk) КАЛІЄВА СІЛЬ N-СУКЦИH-d,l-ТРИПТОФАHУ, ЯКА МАЄ КАРДІОТОHІЧHУ ДІЮ
SU1116706A1 (ru) Производные 2,3,4,5-тетрагидро-1н-1,5-бензодиазепинона-2, проявляющие противовоспалительную активность
SU1111454A1 (ru) Способ получения (4,6-дизамещенный пиримидинил-2)тиофанийбромидов